Coleman Mark sold AXSM
June 10, 2026 · Form 4 insider transaction
Coleman Mark sold 643 shares of Axsome Therapeutics, Inc. at $249.00 per share, a transaction worth $160.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
643
Price
$249.00
Total value
$160.1K
InsiderColeman Mark
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 10, 2026
Filing dateJune 10, 2026
Shares owned after30,389
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.; These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $245.17 and $253.04.